Detalhe da pesquisa
1.
MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway.
Clin Immunol
; 256: 109770, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37717672
2.
Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma.
World J Surg Oncol
; 21(1): 90, 2023 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36899373
3.
Deep-learning-based analysis of preoperative MRI predicts microvascular invasion and outcome in hepatocellular carcinoma.
World J Surg Oncol
; 20(1): 189, 2022 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35676669
4.
Far upstream element-binding protein 1 facilitates hepatocellular carcinoma invasion and metastasis.
Carcinogenesis
; 41(7): 950-960, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587040
5.
ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5.
Cytokine
; 129: 155004, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32058275
6.
New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer.
J Cell Biochem
; 120(4): 6035-6045, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30368883
7.
Differential network analysis depicts regulatory mechanisms for hepatocellular carcinoma from diverse backgrounds.
Future Oncol
; 15(34): 3917-3934, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31729887
8.
Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 10: 697-712, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37138764
9.
Dissecting Intra-Tumoral Changes Following Immune Checkpoint Blockades in Intrahepatic Cholangiocarcinoma via Single-Cell Analysis.
Front Immunol
; 13: 871769, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35558087
10.
Antiviral therapy improves postoperative survival of patients with HBV-related hepatocellular carcinoma.
Am J Surg
; 224(1 Pt B): 494-500, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35115174
11.
The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth.
Cell Oncol (Dordr)
; 45(6): 1435-1449, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36435866
12.
BRG1 regulates lipid metabolism in hepatocellular carcinoma through the PIK3AP1/PI3K/AKT pathway by mediating GLMP expression.
Dig Liver Dis
; 54(5): 692-700, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158256
13.
Exosomal miR-3682-3p Suppresses Angiogenesis by Targeting ANGPT1 via the RAS-MEK1/2-ERK1/2 Pathway in Hepatocellular Carcinoma.
Front Cell Dev Biol
; 9: 633358, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33869178
14.
Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis.
Cell Death Dis
; 12(3): 260, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33707417
15.
MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinoma.
J Cancer
; 11(9): 2476-2484, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32201518
16.
TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection.
Dig Liver Dis
; 52(6): 668-676, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31822388
17.
Long non-coding RNA00364 represses hepatocellular carcinoma cell proliferation via modulating p-STAT3-IFIT2 signaling axis.
Oncotarget
; 8(60): 102006-102019, 2017 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29254221